Canarick Robert 4
4 · INTEGRATED BIOPHARMA INC · Filed May 22, 2025
Insider Transaction Report
Form 4
Canarick Robert
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2025-05-21−175,000→ 0 totalExercise: $0.09Exp: 2025-06-02→ Common Stock (175,000 underlying) - Award
Common Stock
2025-05-21$0.09/sh+175,000$15,750→ 234,233 total
Footnotes (2)
- [F1]175,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
- [F2]75% of the options became exercisable on June 2, 2015 with 25% becoming exercisable in twelve (12) equal monthly installments beginning on July 2, 2015.